← Back to Clinical Trials
Recruiting NCT06405750

Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate

Trial Parameters

Condition Atrial Fibrillation
Sponsor University Hospital Bispebjerg and Frederiksberg
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-01
Completion 2035-12-31
Interventions
left atrial appendage closure

Brief Summary

The purpose of the project is to elucidate whether it is possible to identify which patients are at risk of forming blood clots that can cause stroke based on analysis of the electrocardiogram. In connection with the operation, the small pouch known as the auricle of the heart is closed, which can be completely removed after closing. This procedure is common in patients with atrial fibrillation to protect the brain from stroke. In the project, all patients will have this auricle closed if they agree to participate in the project. After closure, the auricle is usually discarded. We will analyze the blood and the auricle tissue taken (if available) in connection with the operation itself, together with the analysis of the electrocardiogram recorded before the planned heart operation.

Eligibility Criteria

Inclusion Criteria: * signed informed consent AND * planned any open-heart surgery: * CABG * valve repair or replacement * aorta surgery * any combination of the above Exclusion Criteria: * current endocarditis * follow-up not possible

Related Trials